Cardialen Receives FDA Approval to Conduct Clinical Trial of Low-Energy Atrial Fibrillation Treatment View more
Intricon Applauds FDA’s Proposal to Improve Access to Hearing Aid Technology for Millions of Americans, Paving the Way for Over-the-Counter Hearing Aids View more
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel), a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma View more
GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan™ (Gadoterate Meglumine) in Pre-Filled Syringes View more